logo
Search orAI Icon𝛼SK
ENTITY
Amgen Inc

Amgen Inc (AMGN US)

181
Analysis
Health Care • United States
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
more
bearish•Celltrion Healthcare
•06 Feb 2019 11:41

Biosimilar Battlefield: The Remsima/Inflectra Warning

2019 marks an inflection point for Korean biosimilar companies Celltrion Healthcare (091990 KS), Celltrion Inc (068270 KS), and Samsung Biologics...

Logo
Share
bearish•S&P 500 INDEX
•09 Jan 2019 03:12

U.S. Equity Strategy: Oversold Rally Continues

A combination of, optimism surrounding U.S.-China trade talks, and Fed Chairman Powell’s comments have led to a continuation of the oversold bounce...

Logo
Vermilion Research
645 Views
Share
bullish•Amarin Corporation Plc
•07 Jan 2019 11:15

Amarin--2019's Biggest Buyout Target for Big Pharma

Amarin (AMRN US), a US-listed biotech firm, presented the full results of its "Reduce-It" (RI) clinical trial at a conference for the American...

Logo
SC Capital
4.8k Views
Share
bearish•Celltrion Inc
•28 Nov 2018 00:29

Biosimilar Battlefield Update: It's Getting Uglier

A confluence of negative news is causing sharp declines (or trading suspensions) in the share prices of Samsung Biologics Co., (207940...

Logo
Share
bearish•Samsung Biologics
•12 Apr 2018 23:44

A Conversation with Biogen

Biogen Inc (BIIB US) is Samsung Biologics Co., Ltd (207940 KS) 's minority (5.4%) partner in the Samsung Bioepis JV that manufactures and sells...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x